Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • Exploring the Applications and Safety of Chemical Compound with CAS 478020-50-7

નવેમ્બર . 30, 2024 07:47 Back to list

Exploring the Applications and Safety of Chemical Compound with CAS 478020-50-7



Understanding China’s EUK-134 A Focus on CAS 478020-50-7


In recent years, the chemical compound known as EUK-134 has garnered significant attention within the fields of pharmaceutical research and antioxidant studies. With the CAS registry number 478020-50-7, EUK-134 is a synthetic molecule developed to mimic the action of naturally occurring superoxide dismutase and catalase enzymes. This synthetic antioxidant plays a crucial role in protecting cells from oxidative stress, a condition linked with various diseases, including neurodegenerative disorders, cardiovascular diseases, and certain cancers.


The Importance of Antioxidants


Oxidative stress is the imbalance between the production of free radicals and the body’s ability to detoxify their harmful effects through neutralization by antioxidants. Free radicals are reactive molecules that can damage cellular components like DNA, proteins, and lipids, leading to cell dysfunction and death. Antioxidants, such as EUK-134, effectively neutralize free radicals, hence protecting cells and tissues from extensive damage.


Mechanism of Action


EUK-134 functions by mimicking the enzymatic actions of superoxide dismutase (SOD) and catalase. SOD catalyzes the dismutation of the superoxide radical into hydrogen peroxide and oxygen, while catalase further decomposes hydrogen peroxide into water and oxygen. By imitating these essential enzymes, EUK-134 not only helps reduce oxidative stress but also contributes to maintaining cellular homeostasis.


Understanding China’s EUK-134 A Focus on CAS 478020-50-7

Applications in Research


china euk cas 478020-50-7

china euk cas 478020-50-7

The interest in EUK-134 extends into various research avenues. For instance, studies have explored its potential benefits in treatments for ischemia-reperfusion injury, a condition that occurs when blood supply returns to the tissue after a period of lack of oxygen (ischemia). Antioxidants like EUK-134 are being investigated for their ability to reduce the damage inflicted on tissues during the reperfusion phase.


Moreover, EUK-134 is being evaluated in cancer research for its potential to enhance the efficacy of certain chemotherapeutic agents, possibly by preventing oxidative damage that can lead to cancer cell proliferation. The compound has shown promise in various in vitro and in vivo studies, showcasing its protective qualities without significant cytotoxicity to healthy cells.


Considerations and Future Directions


While EUK-134 holds tremendous promise, it is crucial to continue conducting rigorous research to fully understand its mechanisms and potential side effects. The safety profile of synthetic antioxidants, particularly in chronic use scenarios, remains an important consideration. Furthermore, determining optimal dosing regimens and understanding the long-term effects of EUK-134 will be vital as researchers look to translate laboratory findings into clinical applications.


In light of the rising prevalence of chronic diseases associated with oxidative stress, the continued exploration of compounds like EUK-134 is of utmost importance. Its potential to act as a therapeutic agent provides hope for patients suffering from debilitating conditions linked to oxidative damage.


Conclusion


EUK-134 (CAS 478020-50-7) stands as a significant chemical compound in the realm of oxidative stress research and antioxidant therapy. As scientists delve deeper into its properties and potential applications, EUK-134 could lead to innovative approaches in preventing and treating diseases associated with oxidative damage. The future of this compound holds promise for paving the way toward new therapeutic strategies that enhance health outcomes and improve the quality of life for individuals facing challenging health conditions. Continued investment in research and development will be necessary to unlock the full potential of EUK-134 and similar compounds in supporting human health.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
guGujarati
en_USEnglish afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu guGujarati